|
|
|
|
|
Triptorelin Acetate |
|
Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2 |
|
57773-63-4 (net) |
|
For the treatment of advanced hormone-dependent prostate cancer endometriosis and central precocious puberty. Use in reproduction medicine.
|
|
Triptorelin acetate is a potent LHRH agonist. After a transient increase, continuous administration results in down-regulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis. |
|
|
|
|
|
|
|
ÀÌÁ¦Ç°¿¡ ´ëÇØ µî·ÏµÈ ÆǸž÷ü°¡ ¾ø½À´Ï´Ù. |
|
|
|
|
|